Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2001-10-19
2010-02-23
Fubara, Blessing M (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
07666445
ABSTRACT:
Surgically implantable drug delivery systems for long-term delivery of haloperidol containing a biodegradable polymer and haloperidol fabricated into the surgically implantable drug delivery systems via solvent casting and compression molding are provided. Also provided are methods for producing the surgically implantable drug delivery systems and methods for using these systems in the treatment of psychotic disorders such as schizophrenia.
REFERENCES:
patent: 4450150 (1984-05-01), Sidman
patent: 4883666 (1989-11-01), Sabel et al.
patent: 5047536 (1991-09-01), Nichols
patent: 5490962 (1996-02-01), Cima et al.
patent: 5601835 (1997-02-01), Sabel et al.
patent: 5629008 (1997-05-01), Lee
patent: 5648096 (1997-07-01), Gander et al.
patent: 5665428 (1997-09-01), Cha et al.
patent: 5817343 (1998-10-01), Burke
patent: 5871778 (1999-02-01), Kino et al.
patent: 5989463 (1999-11-01), Tracy et al.
patent: 6004573 (1999-12-01), Rathi et al.
patent: 6117949 (2000-09-01), Rathi et al.
patent: 6130200 (2000-10-01), Brodbeck et al.
patent: 6143314 (2000-11-01), Chandrashekar
patent: 6147072 (2000-11-01), Bymaster et al.
patent: 6166173 (2000-12-01), Mao et al.
patent: 6201072 (2001-03-01), Rathi et al.
patent: 6303137 (2001-10-01), Dittgen et al.
patent: 2002/0179096 (2002-12-01), Siegel et al.
patent: 669128 (2000-01-01), None
patent: WO 94/10982 (1994-05-01), None
Cheng et al. “A poly(D, L-lactide-co-glycolide) microsphere depot system for delivery for haloperidol,” J. Controlled Release, 1988, pp. 203-212.
Cheng et al. (J. Controlled Release, 1988, 203-212).
Cheng et al., “A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol,” in Journal of Controlled Release 55 (1998) 203-212.
Domb et al. “(Degradable Polymers for Site-Specific Drug Delivery,” in polymers for Advanced Technologies, vol. 3, pp. 279-292, 1992.
Benelli et al., “Clonazepam microencapsulation in poly-D, L-lactide-co-glycolide microspheres”, J. Microencapsulation 1998 15(4):431-443.
Cheng et al., “A poly (D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol”, J. Controlled Release 1988 203-212.
Cheng et al., “Schizophrenia and Drug Delivery Systems”, J. Drug Targeting 2000 8(2):107-117.
Fischel-Ghodsian et al., “Analysis of Drug Release Kinetics from Degradable Polymeric Devices”, J. Drug Targeting 1993 1:51-57.
Heller J., “Controlled release of biologically active compounds from bioerodible polymers” 1979.
Holland et al., “Polymers for Biodegradable Medical Devices. 1. The Potential of Polyesters as Controlled Macromolecular Release Systems”, J. Controlled Release 1986 4:155-180.
Jain et al., “Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system”, J. Microencapsulation 2000 17(3):343-362.
Kitchell et al., “[32] Poly(lactic/glycolic acid) Biodegradable Drug-Polymer Matrix Systems”, Polymer Systems 1985 436-449.
Köhler et al., “A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers”, Neuroscience Letters 1994 99-102.
Kulkarni et al., “Biodegradable Poly(lactic acid) Polymers”, J. Biomed. Mater. Res. 1971 5:169-181.
Lewis D.H., “Controlled Release of Bioactive Agents from Lactide/Glycolide Polymers”, Biodegradable Polymers as Drug Delivery Systems.
Linhardt R. J., “Biodegradable Polymers for Controlled Release of Drugs”, Biodegradable Polymers 53-83.
Natsugoe et al., “Controlled Release of Cisplatin Incorporated into Biodegradable Poly-d, 1-Lactic Acid”, Anticancer Research 1997 17:1957-1960.
Ron et al., “Erodible Systems”, 199-217.
Roskos et al., “Degradable Controlled Release Systems Useful for Protein Delivery”, Degradable Controlled Release Systems Chapter 2 1997 45-92.
Wada et al., “In Vitro Evaluation of Sustained Drug Release from Biodegradable Elastomer”, Pharmaceutical Research 1991 8(10):1292-1296.
Wang et al., “Synthesis, characterization, bodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: I. Synthesis and characterization”, J. Biomater. Sci. Polymer Edn. 2000 11(3):301-318.
Domb et al “Degradable Polymers for Site-specific Drug Delivery” Polymers for Advanced Technologies, vol. 3, pp. 279-292, 1992.
Santos et al “Clinical implications of determination of plasma haloperidol levels” Acta Psychiatr Scand 1989: 79:348-254.
Gur Raquel E.
Lenox Robert H.
Siegel Steven J.
Winey Karen I.
Cohen Mark S.
Fubara Blessing M
Pearl Cohen Zedek Latzer LLP
The Trustees of the University of Pennsylvania
LandOfFree
Polymer-based surgically implantable haloperidol delivery... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymer-based surgically implantable haloperidol delivery..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer-based surgically implantable haloperidol delivery... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152423